Magnetar Financial LLC trimmed its stake in Becton, Dickinson and Company (NYSE:BDX) by 60.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,171 shares of the medical instruments supplier’s stock after selling 19,910 shares during the quarter. Magnetar Financial LLC’s holdings in Becton, Dickinson and were worth $2,581,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cypress Capital Group lifted its stake in shares of Becton, Dickinson and by 84.6% during the 1st quarter. Cypress Capital Group now owns 4,615 shares of the medical instruments supplier’s stock valued at $847,000 after buying an additional 2,115 shares in the last quarter. BlueCrest Capital Management Ltd purchased a new stake in shares of Becton, Dickinson and during the 1st quarter valued at approximately $789,000. Investment Centers of America Inc. lifted its stake in shares of Becton, Dickinson and by 0.6% during the 1st quarter. Investment Centers of America Inc. now owns 3,922 shares of the medical instruments supplier’s stock valued at $721,000 after buying an additional 22 shares in the last quarter. Endurant Capital Management LP lifted its stake in shares of Becton, Dickinson and by 49.4% during the 1st quarter. Endurant Capital Management LP now owns 70,201 shares of the medical instruments supplier’s stock valued at $12,878,000 after buying an additional 23,201 shares in the last quarter. Finally, Edgestream Partners L.P. lifted its stake in shares of Becton, Dickinson and by 424.7% during the 1st quarter. Edgestream Partners L.P. now owns 6,879 shares of the medical instruments supplier’s stock valued at $1,262,000 after buying an additional 5,568 shares in the last quarter. Hedge funds and other institutional investors own 88.46% of the company’s stock.

In other Becton, Dickinson and news, insider Gary M. Cohen sold 15,512 shares of the stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $203.77, for a total value of $3,160,880.24. Following the sale, the insider now directly owns 95,781 shares in the company, valued at approximately $19,517,294.37. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.40% of the company’s stock.

Shares of Becton, Dickinson and Company (NYSE:BDX) opened at $217.81 on Friday. Becton, Dickinson and Company has a 52 week low of $161.50 and a 52 week high of $229.68. The company has a quick ratio of 5.03, a current ratio of 5.58 and a debt-to-equity ratio of 1.44. The stock has a market cap of $49,660.00, a P/E ratio of 23.07, a price-to-earnings-growth ratio of 1.71 and a beta of 1.06.

Becton, Dickinson and (NYSE:BDX) last posted its earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.37 by $0.03. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 20.56%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.14 billion. During the same period in the prior year, the company posted $2.12 EPS. The business’s revenue for the quarter was down 2.0% compared to the same quarter last year. equities analysts anticipate that Becton, Dickinson and Company will post 10.63 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 8th will be paid a $0.75 dividend. The ex-dividend date of this dividend is Thursday, December 7th. This is a boost from Becton, Dickinson and’s previous quarterly dividend of $0.73. This represents a $3.00 annualized dividend and a yield of 1.38%. Becton, Dickinson and’s dividend payout ratio is currently 62.80%.

A number of analysts recently commented on BDX shares. Zacks Investment Research upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $234.00 price target on the stock in a research note on Tuesday, October 31st. Piper Jaffray Companies restated a “buy” rating and set a $213.00 price target on shares of Becton, Dickinson and in a research note on Tuesday, September 12th. BidaskClub upgraded shares of Becton, Dickinson and from a “hold” rating to a “buy” rating in a research note on Monday, August 14th. Cowen restated a “buy” rating and set a $230.00 price target on shares of Becton, Dickinson and in a research note on Monday, August 14th. Finally, Stifel Nicolaus restated a “buy” rating and set a $245.00 price target on shares of Becton, Dickinson and in a research note on Friday, November 3rd. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $217.08.

COPYRIGHT VIOLATION WARNING: This article was posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The correct version of this article can be read at https://www.dailypolitical.com/2017/12/08/becton-dickinson-and-company-bdx-shares-sold-by-magnetar-financial-llc.html.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.